Longeveron Rights Offering Declared Effective and Calendar Finalized
MIAMI, Aug. 16, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
MIAMI, Aug. 16, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”),…
PHILADELPHIA, PA, Aug 16, 2023 – (ACN Newswire) – In addition to helping alleviate a…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
The partnership will provide community OneOncology Research Network sites with new tools to accelerate clinical…
Machine learning models will allow CMP, NYSEG, RG&E and UI to forecast grid performance ahead…
Nashville Fintech Becomes Popular Music Venue’s Preferred Payments Partner NASHVILLE, Tenn.–(BUSINESS WIRE)–#BluebirdCafe—Celero Commerce (“Celero”), a…
ITERATE Design and Innovation uses 3D printing across prototyping and production, outsourcing volume runs to specialist bureaux for speed and quality.
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
LOS ANGELES, Aug. 16, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or…
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with…
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
Announces Additional Management Changes; Independent Directors Now Majority of Board TARRYTOWN, NY, Aug. 16, 2023…
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
Initial data show clinical responses from four of four indolent lymphoma patients, including complete response…
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…
BRIDGEWATER, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or…